Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells.

Research output: Contribution to journalJournal articleResearchpeer-review

In this study, we characterize the molecular signal pathways that lead to MHC class I chain-related protein A (MICA) expression after histone deacetylase (HDAC)-inhibitor (HDAC-i) treatment of Jurkat T cells. Chelating calcium with BAPTA-AM or EGTA potently inhibited HDAC- and CMV-mediated MICA/B expression. It was further observed that endoplasmic reticulum calcium stores were depleted after HDAC treatment. NF-kappaB activity can be induced by HDAC treatment. However, nuclear translocation of NF-kappaB p65 was not observed after HDAC treatment of Jurkat T cells and even though we could effectively inhibit p65 expression by siRNA, it did not modify MICA/B expression. To identify important elements in MICA regulation, we made a promoter construct consisting of approximately 3 kb of the proximal MICA promoter in front of GFP. Deletion analysis showed that a germinal center-box containing a putative Sp1 site from position -113 to -93 relative to the mRNA start site was important for HDAC and CMV-induced promoter activity. Sp1 was subsequently shown to be important, as targeted mutation of the Sp1 binding sequence or siRNA mediated down modulation of Sp1-inhibited MICA promoter activity and surface-expression.
Original languageEnglish
JournalJournal of Immunology
Volume179
Issue number12
Pages (from-to)8235-42
Number of pages7
ISSN0022-1767
Publication statusPublished - 2007

Bibliographical note

Keywords: Active Transport, Cell Nucleus; Calcium; Chelating Agents; Cytomegalovirus; Depsipeptides; Egtazic Acid; Endoplasmic Reticulum; Enzyme Inhibitors; Gene Expression Regulation; Histocompatibility Antigens Class I; Histone Deacetylases; Humans; Jurkat Cells; Promoter Regions (Genetics); RNA, Small Interfering; Sp1 Transcription Factor; T-Lymphocytes; Transcription Factor RelA

ID: 5695492